Edwin Sonneveld

7.5k total citations · 1 hit paper
95 papers, 4.3k citations indexed

About

Edwin Sonneveld is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Hematology. According to data from OpenAlex, Edwin Sonneveld has authored 95 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Public Health, Environmental and Occupational Health, 43 papers in Molecular Biology and 41 papers in Hematology. Recurrent topics in Edwin Sonneveld's work include Acute Lymphoblastic Leukemia research (43 papers), Acute Myeloid Leukemia Research (28 papers) and Chronic Myeloid Leukemia Treatments (19 papers). Edwin Sonneveld is often cited by papers focused on Acute Lymphoblastic Leukemia research (43 papers), Acute Myeloid Leukemia Research (28 papers) and Chronic Myeloid Leukemia Treatments (19 papers). Edwin Sonneveld collaborates with scholars based in Netherlands, Germany and United States. Edwin Sonneveld's co-authors include Abraham Brouwer, Paul T. van der Saag, Jorke H. Kamstra, Timo Hamers, Bart van der Burg, Albertinka J. Murk, Patrik L. Andersson, Monique H. A. Kester, Juliette Legler and Rob Pieters and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Edwin Sonneveld

93 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Vitro Profiling of the Endocrine-Disrupting Potency of Brominated Flame Retardants

2006 604 citations Timo Hamers, Jorke H. Kamstra et al. Toxicological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edwin Sonneveld Netherlands	35	1.6k	1.4k	1.0k	1.0k	555	95	4.3k
Jordi Surrallés Spain	34	3.0k 1.8×	907 0.6×	191 0.2×	206 0.2×	638 1.1×	109	5.3k
Mary Beth Martin United States	33	1.2k 0.7×	1.7k 1.2×	83 0.1×	200 0.2×	1.4k 2.5×	71	4.3k
Barbara F. Hales Canada	43	2.1k 1.3×	1.5k 1.1×	41 0.0×	1.9k 1.9×	424 0.8×	195	5.8k
Yasushi Takai Japan	33	1.3k 0.8×	1.6k 1.1×	35 0.0×	1.1k 1.1×	547 1.0×	130	4.4k
Takatoshi Ishikawa Japan	31	2.5k 1.6×	533 0.4×	301 0.3×	159 0.2×	550 1.0×	116	5.5k
Hong Sun United States	46	7.5k 4.7×	686 0.5×	241 0.2×	225 0.2×	513 0.9×	125	10.0k
Robert M. Bigsby United States	39	1.7k 1.0×	2.0k 1.5×	50 0.0×	297 0.3×	1.3k 2.4×	91	5.8k
William A. Ricke United States	36	1.4k 0.9×	647 0.5×	66 0.1×	202 0.2×	692 1.2×	119	4.7k
Brigitte Le Magueresse‐Battistoni France	29	609 0.4×	610 0.4×	91 0.1×	411 0.4×	434 0.8×	65	2.1k
William Ka Fai Tse Japan	32	913 0.6×	343 0.2×	214 0.2×	73 0.1×	254 0.5×	107	2.5k

Countries citing papers authored by Edwin Sonneveld

Since Specialization

Citations

This map shows the geographic impact of Edwin Sonneveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Sonneveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Sonneveld more than expected).

Fields of papers citing papers by Edwin Sonneveld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin Sonneveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Sonneveld. The network helps show where Edwin Sonneveld may publish in the future.

Co-authorship network of co-authors of Edwin Sonneveld

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin Sonneveld. A scholar is included among the top collaborators of Edwin Sonneveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin Sonneveld. Edwin Sonneveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boeree, Aurélie, et al.. (2025). Secondary lesions and sensitivity to signaling inhibitors in iAMP21 acute lymphoblastic leukemia. HemaSphere. 9(1). e70069–e70069. 2 indexed citations

Antić, Željko, Stefan H. Lelieveld, Marley Yeong, et al.. (2024). Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia. Leukemia. 38(11). 2366–2375. 3 indexed citations

Hoogerbrugge, Peter M., Judith M. Boer, Edwin Sonneveld, et al.. (2024). ABL-Class Fusion Gene Induced Pediatric CML Presenting As ALL. Blood. 144(Supplement 1). 5851–5851. 1 indexed citations

Tregnago, Claudia, Rhonda E. Ries, Todd A. Alonzo, et al.. (2024). Influence of Nucleophosmin ( NPM1 ) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration. Journal of Clinical Oncology. 43(8). 972–984. 1 indexed citations

Boeree, Aurélie, Edwin Sonneveld, Anthony V. Moorman, et al.. (2023). Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations. SHILAP Revista de lepidopterología. 3. 100140–100140. 2 indexed citations

Boeree, Aurélie, Cesca van de Ven, Gabriele Escherich, et al.. (2023). Secondary Lesions and Sensitivity to Signaling Inhibitors of Pediatric iAMP21 B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 142(Supplement 1). 1613–1613. 1 indexed citations

Boeree, Aurélie, et al.. (2023). Integrating copy number data of 64 iAMP21 BCP-ALL patients narrows the common region of amplification to 1.57 Mb. Frontiers in Oncology. 13. 1128560–1128560. 3 indexed citations

Merli, Pietro, Christiane Walter, Claudia Tregnago, et al.. (2022). Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group. Biomedicines. 10(7). 1530–1530. 4 indexed citations

Sędek, Łukasz, Juan Flores‐Montero, Jan Philippé, et al.. (2022). Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels. Cancers. 14(3). 473–473. 2 indexed citations

10.

Obulkasim, Askar, Daria G. Valerio, Edwin Sonneveld, et al.. (2017). MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML. Oncogene. 37(1). 107–115. 14 indexed citations

11.

Yu, Jiangyan, Željko Antić, Simon V. van Reijmersdal, et al.. (2017). Accurate detection of low-level mosaic mutations in pediatric acute lymphoblastic leukemia using single molecule tagging and deep-sequencing. Leukemia & lymphoma. 59(7). 1690–1699. 5 indexed citations

12.

Moorman, Anthony V., Julie Irving, Amir Enshaei, et al.. (2015). Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia. Haematologica. 100. 195–196. 3 indexed citations

13.

Sarmento, Leonor M., Kirsten Canté-Barrett, Linda Zuurbier, et al.. (2014). PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events. Blood. 124(4). 567–578. 60 indexed citations

14.

Veer, Arian van der, Esmé Waanders, Rob Pieters, et al.. (2013). Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood. 122(15). 2622–2629. 187 indexed citations

15.

Sonneveld, Edwin, et al.. (2006). Glucocorticoid mediated expression of dioxin target genes in rat H4IIe cells but not in human HepG2 and T47D cells. VU Research Portal. 68. 564–567. 1 indexed citations

16.

Sonneveld, Edwin, et al.. (2005). Comparison of In Vitro and In Vivo Screening Models for Androgenic and Estrogenic Activities. Toxicological Sciences. 89(1). 173–187. 149 indexed citations

17.

Hamers, Timo, Jorke H. Kamstra, Edwin Sonneveld, et al.. (2004). In vitro screening of the endocrine disrupting potency of brominated flame retardants and their metabolites. VU Research Portal. 66. 3016–3020. 4 indexed citations

18.

Brouwer, A., et al.. (2004). A low volume method for the analysis of dioxins and dioxin-like compounds in serum and whole blood using BDS¿ Dr Calux® Bioassay. Data Archiving and Networked Services (DANS). 66. 700–703. 3 indexed citations

19.

Sonneveld, Edwin, et al.. (2003). Calux® reporter cell lines as sensitive bioassay for monitoring biological activity of various classes of steroid hormones revert the repressive effect of TCDD on the estrogen receptor. Organohalogen compounds. 60(24). 263–266. 1 indexed citations

20.

Sonneveld, Edwin, C.E. van den Brink, Jeannette Jansen, et al.. (2002). Development of improved DR-CALUX bioassay for sensitive measurement of aryl hydrocarbon receptor activating compounds. VU Research Portal. 58. 369–372. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact